Add-on to Cognitive, Event-Related Potentials (ERP) and Electroencephalogram (EEG) Asymmetry in Affective Disorders

Withdrawn before enrolling · Phase 4

Conditions studied: Depressive Illness

In brief

Depressed patients unremitted after monotherapy with citalopram or bupropion will remit following six weeks treatment with the combination of citalopram and bupropion.

Key facts

Study ID

NCT03278938

Run by

New York State Psychiatric Institute

People needed

0

Starts

2012-06-29

Expected to finish

2016-01-01

Last updated by the study team

2019-03-15

Who can join

Age: 18 and older, up to 66. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• non-remission in Protocol #6559R
• age 18-66
• signs informed consent
• physically healthy

You may not qualify if…

• bipolar disorder
• history of psychosis
• history of anorexia nervosa or bulimia
• history of seizure disorder, significant brain trauma or other medical reason to suspect increased seizure risk

Where it is running

• New York State Psychiatric Institute — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.